Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
2872
|
2897
|
0.310 |
None |
1.000 |
1 |
|
2010 |
2010 |
Reticulosarcoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
80
|
2
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
nervous system disorder
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
977
|
39
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Lymphoma, Undifferentiated
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
25
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Lymphoma, Mixed-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Lymphoma, Small Noncleaved-Cell
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
32
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Adverse reaction to drug
|
group |
Chemically-Induced Disorders
|
Pathologic Function
|
87
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Lymphoma, Intermediate-Grade
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
24
|
2
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Diffuse Mixed-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
21
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Lymphoma, Diffuse
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
49
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Low Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
39
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
High Grade Lymphoma (neoplasm)
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
62
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2007 |
2007 |
Waist-Hip Ratio
|
phenotype |
|
Organism Attribute
|
565
|
1138
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Blood Protein Measurement
|
phenotype |
|
Laboratory Procedure
|
1156
|
2575
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Congenital defects
|
group |
|
Congenital Abnormality
|
126
|
6
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Papillary thyroid carcinoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
1348
|
204
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Childhood Non-Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
371
|
39
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Adult Non-Hodgkin Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
370
|
39
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Medullary carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
81
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Anaplastic carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
232
|
3
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Secondary malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
1370
|
20
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hyperphosphatemia (disorder)
|
disease |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
65
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |